A cost-efficacy analysis of subcutaneous anti–tumor necrosis factor therapy in the treatment of psoriatic arthritis

2012 ◽  
Vol 66 (4) ◽  
pp. AB6
Keyword(s):  
Psoriatic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Efficacy Analysis ◽  
Cost Efficacy ◽  
Factor Therapy ◽  
Necrosis Factor

PDE3A-SLCO1C1locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

2014 ◽  
Vol 15 (14) ◽  
pp. 1763-1769 ◽  
Author(s):  
Antonio Julià ◽  
Jesús Rodríguez ◽  
José Luis Fernández-Sueiro ◽  
Jordi Gratacós ◽  
Rubén Queiró ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Factor Therapy ◽  
Necrosis Factor

scholarly journals Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area

Clinics ◽  
2020 ◽  
Vol 75 ◽  
Author(s):  
Andrea Yukie Shimabuco ◽  
Ana Cristina de Medeiros-Ribeiro ◽  
Renata Miossi ◽  
Karina Rossi Bonfiglioli ◽  
Julio Cesar Bertacini de Moraes ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Endemic Area ◽  
Latent Tuberculosis Infection ◽  
Latent Tuberculosis ◽  
Factor Therapy ◽  
Necrosis Factor

Minimal Disease Activity and Anti-Tumor Necrosis Factor Therapy in Psoriatic Arthritis

2015 ◽  
Vol 67 (6) ◽  
pp. 842-847 ◽  
Author(s):  
Amir Haddad ◽  
Arane Thavaneswaran ◽  
Ioana Ruiz-Arruza ◽  
Fawnda Pellett ◽  
Vinod Chandran ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Tumor Necrosis Factor ◽  
Disease Activity ◽  
Tumor Necrosis ◽  
Minimal Disease Activity ◽  
Factor Therapy ◽  
Minimal Disease ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document